Skip to main content
PMC home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1991 Mar;29(3):431–435. doi: 10.1128/jcm.29.3.431-435.1991

New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies.

T F Schwarz 1, S Modrow 1, B Hottenträger 1, B Höflacher 1, G Jäger 1, W Scharti 1, R Sumazakl 1, H Wolf 1, J Middeldorp 1, M Roggendorf 1, et al.
PMCID: PMC269794  PMID: 1645365

Abstract

A new, highly sensitive and specific enzyme immunoassay using oligopeptides as antigen (enzyme-linked immunosorbent assay [ELISA] B19-OP) for detecting parvovirus B19-specific immunoglobulin G (IgG) was established. As antigens, B19-specific oligopeptides of 24 and 30 kDa derived from a 196-kDa fusion protein of beta-galactosidase and viral capsid protein (VPI) of B19 after CNBr cleavage and separation by high-pressure liquid chromatography were used. Of 139 serum specimens tested in parallel for anti-B19 IgG by standard ELISA using B19 particles as antigen and by ELISA B19-OP, 73 (52.5%) were positive and 63 (45.3%) were negative in both tests, and 3 (2.2%) were negative by standard ELISA but positive by ELISA B19-OP and by immunoblot. By using ELISA B19-OP, it was possible to detect anti-B19 IgG in an asymptomatic blood donor 4 weeks after acute infection, and anti-B19 IgG titers of 10(-5) could be measured in convalescent-phase sera.

Full text

PDF
433

Images in this article

432Image
on p.432

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson L. J., Tsou C., Parker R. A., Chorba T. L., Wulff H., Tattersall P., Mortimer P. P. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986 Oct;24(4):522–526. doi: 10.1128/jcm.24.4.522-526.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson M. J., Davis L. R., Jones S. E., Pattison J. R., Serjeant G. R. The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus-like agent. J Hyg (Lond) 1982 Apr;88(2):309–324. doi: 10.1017/s0022172400070169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson M. J., Lewis E., Kidd I. M., Hall S. M., Cohen B. J. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Lond) 1984 Aug;93(1):85–93. doi: 10.1017/s0022172400060964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Anderson M. J., Pattison J. R. The human parvovirus. Brief review. Arch Virol. 1984;82(3-4):137–148. doi: 10.1007/BF01311158. [DOI] [PubMed] [Google Scholar]
  5. Bartolomei Corsi O., Azzi A., Morfini M., Fanci R., Rossi Ferrini P. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol. 1988 Jun;25(2):165–170. doi: 10.1002/jmv.1890250206. [DOI] [PubMed] [Google Scholar]
  6. Cohen B. J., Couroucé A. M., Schwarz T. F., Okochi K., Kurtzman G. J. Laboratory infection with parvovirus B19. J Clin Pathol. 1988 Sep;41(9):1027–1028. doi: 10.1136/jcp.41.9.1027-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cohen B. J., Mortimer P. P., Pereira M. S. Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV). J Hyg (Lond) 1983 Aug;91(1):113–130. doi: 10.1017/s0022172400060095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cossart Y. E., Field A. M., Cant B., Widdows D. Parvovirus-like particles in human sera. Lancet. 1975 Jan 11;1(7898):72–73. doi: 10.1016/s0140-6736(75)91074-0. [DOI] [PubMed] [Google Scholar]
  9. Fridell E., Trojnar J., Wahren B. A new peptide for human parvovirus B19 antibody detection. Scand J Infect Dis. 1989;21(6):597–603. doi: 10.3109/00365548909021686. [DOI] [PubMed] [Google Scholar]
  10. Kajigaya S., Shimada T., Fujita S., Young N. S. A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7601–7605. doi: 10.1073/pnas.86.19.7601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kalnins A., Otto K., Rüther U., Müller-Hill B. Sequence of the lacZ gene of Escherichia coli. EMBO J. 1983;2(4):593–597. doi: 10.1002/j.1460-2075.1983.tb01468.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kurtzman G. J., Cohen B., Meyers P., Amunullah A., Young N. S. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet. 1988 Nov 19;2(8621):1159–1162. doi: 10.1016/s0140-6736(88)90233-4. [DOI] [PubMed] [Google Scholar]
  13. Mortimer P. P., Luban N. L., Kelleher J. F., Cohen B. J. Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet. 1983 Aug 27;2(8348):482–484. doi: 10.1016/s0140-6736(83)90512-3. [DOI] [PubMed] [Google Scholar]
  14. Schwarz T. F., Roggendorf M., Deinhardt F. Human parvovirus B19: ELISA and immunoblot assays. J Virol Methods. 1988 Jun;20(2):155–168. doi: 10.1016/0166-0934(88)90149-8. [DOI] [PubMed] [Google Scholar]
  15. Schwarz T. F., Roggendorf M., Hottenträger B., Deinhardt F., Enders G., Gloning K. P., Schramm T., Hansmann M. Human parvovirus B19 infection in pregnancy. Lancet. 1988 Sep 3;2(8610):566–567. doi: 10.1016/s0140-6736(88)92684-0. [DOI] [PubMed] [Google Scholar]
  16. Shade R. O., Blundell M. C., Cotmore S. F., Tattersall P., Astell C. R. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol. 1986 Jun;58(3):921–936. doi: 10.1128/jvi.58.3.921-936.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES